 |
FTI Consulting handles Abcam as the British biotechnology company agrees to a $5.7B takeover from DC-based Danaher Corp., which chalked up $31.5B in fiscal 2022 revenues.
Abcam will operate as a standalone company in Danaher’s life sciences division to bolster its strategy “to help map complex diseases and accelerate the drug discovery process."
Founded in Cambridge in 1998, Abcam’s validated antibodies, reagents, biomarkers and assays are used by an estimated 750K researchers.
Danaher CEO Rainer Blair said Abcam’s long track record of innovation and breadth of antibody portfolio positions makes it a key partner for the scientific community.
The transaction is expected to close mid-2024.
C Street Advisory handles iRobot Corp as the marketer of the Roomba autonomous vacuum cleaner files Chapter 11 after being squeezed by cheaper competitors.
Joele Frank represents Confluent Inc. as the Mountain View, CA-based data streaming platform company agrees to be acquired by IBM in a deal with an enterprise value of $11B.
Tom Johnson, who has headed H/Advisors Abernathy since 2016, will join FGS Global as global head of private capital & financial services, effective Dec. 16.
Brunswick Group and Gagnier Communications are handling Paramount’s $30 cash per-share offer for all of Warner Bros Discovery, topping Netflix $27.50 cash/stock transaction.
ICR Inc. handles communications for Enhanced Ltd, which plans to run Olympic-type competitions with athletes using performance-enhancing drugs, as it goes public in a SPAC deal valued at $1.2B via a merger with A Paradise Acquisition Corp. of Hong Kong.
